Shandong Sinobioway Biomedicine Co Ltd (002581)

Shenzhen
Currency in CNY
8.98
-0.47(-4.97%)
Closed·
002581 Scorecard
Full Analysis
Impressive gross profit margins
002581 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.988.98
52 wk Range
5.6914.43
Key Statistics
Edit
Bid/Ask
9.45 / 9.45
Prev. Close
9.45
Open
8.98
Day's Range
8.98-8.98
52 wk Range
5.69-14.43
Volume
190K
Average Volume (3m)
16.22M
1-Year Change
-2.39%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002581 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Shandong Sinobioway Biomedicine Co Ltd Company Profile

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates in China. The company manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, and trimethyl acetate and its by-products. It also offers Anfulan, a human interferon a2b injection; Jiefu, a human interferon a2b spray; Enjingfu, a mouse nerve growth factor for injection; and Bellaph, a combined hepatitis A and B vaccine. In addition, the company is involved in biopharmaceutical research and development services, including cell line development and cell bank building, cell culture process development, protein purification process development, preparation prescription and process development, analysis and detection method development, and quality research. Further, it provides biopharmaceutical production services, such as preclinical, clinical phase I/II/III and commercial manufacturing; and other services, including regulatory service support and drug registration affairs. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

Employees
476
Market
China

Compare 002581 to Peers and Sector

Metrics to compare
002581
Peers
Sector
Relationship
P/E Ratio
−40.5x−21.5x−0.5x
PEG Ratio
−0.710.060.00
Price/Book
3.1x3.1x2.6x
Price / LTM Sales
19.0x7.3x3.2x
Upside (Analyst Target)
-0.6%45.4%
Fair Value Upside
Unlock−10.2%6.9%Unlock

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
35.33M / --
EPS Revisions
Last 90 days

002581 Income Statement

FAQ

What Stock Exchange Does Shandong Sinobioway Biomedicine Trade On?

Shandong Sinobioway Biomedicine is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Shandong Sinobioway Biomedicine?

The stock symbol for Shandong Sinobioway Biomedicine is "002581."

What Is the Shandong Sinobioway Biomedicine Market Cap?

As of today, Shandong Sinobioway Biomedicine market cap is 5.92B.

What Is Shandong Sinobioway Biomedicine's Earnings Per Share (TTM)?

The Shandong Sinobioway Biomedicine EPS (TTM) is -0.22.

From a Technical Analysis Perspective, Is 002581 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Shandong Sinobioway Biomedicine Stock Split?

Shandong Sinobioway Biomedicine has split 2 times.

How Many Employees Does Shandong Sinobioway Biomedicine Have?

Shandong Sinobioway Biomedicine has 476 employees.

What is the current trading status of Shandong Sinobioway Biomedicine (002581)?

As of 13 Jul 2025, Shandong Sinobioway Biomedicine (002581) is trading at a price of 8.98, with a previous close of 9.45. The stock has fluctuated within a day range of 8.98 to 8.98, while its 52-week range spans from 5.69 to 14.43.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.